Clinical Trial Update: An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a new formulation of ketoconazole 2% cream for tinea pedis (athlete's foot); the study was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• Ketoconazole 2% Cream (new formulation) (ketoconazole)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Tinea Pedis | Phase 3 | Status: TERMINATED | Results posted: 2013-06-06